menu ☰
menu ˟

Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study

23 Mar 2018

Tofacitinib is the first oral Janus kinase inhibitor approved for the treatment of rheumatoid arthritis (RA). We compared the effectiveness and safety of tofacitinib, disease-modifying antirheumatic drugs (DMA...

Click here to view the full article which appeared in Arthritis Research & Therapy